Antengene Appoints Dr. Bing Hou as Chief Scientific Officer to Lead Innovation-Driven R&D Strategy and Advance Next-Generation Pipeline

B SHANGHAI and HONG KONG, May 19, 2026 /PRNewswire/ — Antengene Corporation Limited  (“Antengene”, SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to…
posteditor
posteditor
Articles: 21727

Other News